Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate

US10087183B2 · kind B2 · utility

Assignee

• Adverio Pharma GmbH · DE

Inventors

• Birgit Keil · Düsseldorf, DE
• Franz-Josef Mais · Düsseldorf, DE
• Winfried Joentgen · Neunburg vorm Wald, DE
• Alfons Grunenberg · Wuppertal, DE

Key dates

• Filing date: Aug 9, 2017
• Grant date: Oct 2, 2018
• Expiry date: Aug 9, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This present invention relates to forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methylcarbamate comprising its Modification I, Modification II, mono-DMSO solvate, sesqui-DMSO solvate and ¼-ethyl acetate solvate.